drugset / Trial / NCT01062906
Intravenous Lidocaine for Laparoscopic Cholecystectomy
Completed
80 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedParallel-groupTriple-blindTreatment
Summary
Intravenous lidocaine has been shown to have analgesic, antinflammatory, antihyperalgesic, antithrombotics and neuroprotective properties. In a previous study conducted in patients undergoing laparoscopic cholecystectomy under general anesthesia with desflurane and fentanyl, intraoperative i.v. infusion of lidocaine spared opioids consumption in the recovery room by 30%. The purpose of this study was to determine if an i.v. infusion of lidocaine without intraoperative opioids would reduce the amount of fentanyl to the same extent and opioids-related side effects.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fentanyl | Other / unclassified | 3 ug/kg | Intravenous |
| Comparator | Lidocaine | Other / unclassified | 2 mg/kg | Intravenous |
Indications
No indication recorded.